Nick Leschly

Chief Executive Officer, bluebird bio

BSc in Molecular Biology, Princeton University; MBA, Wharton Business School. Former: Partner, Third Rock Ventures; Velcade Project Lead, Millennium Pharmaceuticals; Founder and Chief Executive Officer, MedXtend Corporation. Since March 2010, Chief Executive Officer, bluebird bio. Member of the Board, Biotechnology Industry Organization.

About us

Engage with us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2025 World Economic Forum